DK1845093T3 - Ny krystallinsk og stabil form af andolast - Google Patents

Ny krystallinsk og stabil form af andolast

Info

Publication number
DK1845093T3
DK1845093T3 DK06112427T DK06112427T DK1845093T3 DK 1845093 T3 DK1845093 T3 DK 1845093T3 DK 06112427 T DK06112427 T DK 06112427T DK 06112427 T DK06112427 T DK 06112427T DK 1845093 T3 DK1845093 T3 DK 1845093T3
Authority
DK
Denmark
Prior art keywords
andolast
new crystalline
stable form
conditions
disodium
Prior art date
Application number
DK06112427T
Other languages
Danish (da)
English (en)
Inventor
Antonio Giordani
Paolo Senin
Francesco Makovec
Walter Peris
Lucio Claudio Rovati
Antonino Santoro
Matteo Ghirri
Paola Gilotta
Original Assignee
Rottapharm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rottapharm Spa filed Critical Rottapharm Spa
Application granted granted Critical
Publication of DK1845093T3 publication Critical patent/DK1845093T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Liquid Crystal Substances (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK06112427T 2006-04-10 2006-04-10 Ny krystallinsk og stabil form af andolast DK1845093T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06112427A EP1845093B1 (en) 2006-04-10 2006-04-10 A new crystalline and stable form of andolast

Publications (1)

Publication Number Publication Date
DK1845093T3 true DK1845093T3 (da) 2009-09-14

Family

ID=36942320

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06112427T DK1845093T3 (da) 2006-04-10 2006-04-10 Ny krystallinsk og stabil form af andolast

Country Status (11)

Country Link
US (2) US7824710B2 (ja)
EP (1) EP1845093B1 (ja)
JP (1) JP5265876B2 (ja)
AT (1) ATE433443T1 (ja)
AU (1) AU2007200816B2 (ja)
CA (1) CA2579333A1 (ja)
DE (1) DE602006007211D1 (ja)
DK (1) DK1845093T3 (ja)
ES (1) ES2327265T3 (ja)
PL (1) PL1845093T3 (ja)
PT (1) PT1845093E (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7444197B2 (en) 2004-05-06 2008-10-28 Smp Logic Systems Llc Methods, systems, and software program for validation and monitoring of pharmaceutical manufacturing processes
US7799273B2 (en) 2004-05-06 2010-09-21 Smp Logic Systems Llc Manufacturing execution system for validation, quality and risk assessment and monitoring of pharmaceutical manufacturing processes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1232252B (it) 1989-02-22 1992-01-28 Rotta Research Lab Derivati della n fenil benzamide ad attivita' antiulcera ed antiallerica e procedimento per la loro preparazione
ATE241980T1 (de) * 1997-08-08 2003-06-15 Rotta Research Lab Neue inhalationspräparate enthaltend cr 2039 (andolast)
PT1634595E (pt) 2004-08-19 2008-08-28 Rottapharm Spa Derivados de n-fenilbenzamida como fármacos para o tratamento doença pulmonar obstativa crónica (dpoc)

Also Published As

Publication number Publication date
PT1845093E (pt) 2009-08-17
PL1845093T3 (pl) 2009-11-30
ES2327265T3 (es) 2009-10-27
AU2007200816A1 (en) 2007-10-25
EP1845093A1 (en) 2007-10-17
DE602006007211D1 (de) 2009-07-23
CA2579333A1 (en) 2007-10-10
US20110086896A1 (en) 2011-04-14
AU2007200816B2 (en) 2012-11-01
JP2007277228A (ja) 2007-10-25
JP5265876B2 (ja) 2013-08-14
ATE433443T1 (de) 2009-06-15
US20070149586A1 (en) 2007-06-28
US7824710B2 (en) 2010-11-02
EP1845093B1 (en) 2009-06-10

Similar Documents

Publication Publication Date Title
ES2362788T3 (es) Compuesto de indolina y proceso para la producción del mismo.
ES2314593T3 (es) Forma cristalina alfa de ranelato de estroncio, su procedimiento de preparacion y composiciones farmaceuticas que la contienen.
ES2626645T3 (es) Proceso para la preparación de aminopirrolidinas quirales ópticamente activas (3-AP, B3-AP)
HUP0400781A2 (hu) Eljárás (R)- vagy (S)-lansoprazol kristályosítására, az előállított kristályok, azokat tartalmazó gyógyszerkészítmények és alkalmazásuk
MXPA04004464A (es) Compuestos de heteroarilo sustituido con azabiciclo para el tratamiento de enfermedades.
DK1897558T3 (da) Fast præparat af 2-hexadecyloxy-6-methyl-4h-3,1-benzoxazin-4-on
NO339021B1 (no) (S)-(-)-1-(4-fluorisokinolin-5-yl)-sulfonyl-2-metyl-1,4-homopiperazinhydrokloriddihydrat samt fremgangsmåte for fremstilling av samme
BRPI0620527A2 (pt) polimorfo cristalino da forma i, polimorfo cristalino da forma ii, mistura de polimorfos da forma i e forma ii, processo para preparar um polimorfo cristalino da forma i, processo para preparar um polimorfo cristalino da forma ii, processo para preparar uma mistura de um polimorfo cristalino da forma i e da forma ii, composição para combater insetos, ácaros, fungos e bactérias, método para combater insetos, ácaros, fungos e bactérias, método para proteger colheitas de seres vivos nocivos, processo para preparar um composto de piridinamina, processo para purificar um composto, processo para preparar e purificar 3-cloro-n-(-3-cloro-5-trifluorometil-2-piridil)-a,a,a-t rifluoro-2, 6-dinitro-p-toluidina (fluazinam) e processo para preparar fluazinam
DK1845093T3 (da) Ny krystallinsk og stabil form af andolast
AR056721A1 (es) Preparado farmaceutico oral estabilizado que contiene clopidogrel bisulfato
NO20054345L (no) Fremgangsmate for termisk stabilisering av hoykonsentrerte formaldehydlosninger
Fini et al. Diclofenac salts, part 7: Are the pharmaceutical salts with aliphatic amines stable?
PT2060568E (pt) Polimorfos de erdosteína enantiopura
Polenske et al. The binary phase diagram of propranolol hydrochloride and crystallization‐based enantioseparation
ATE261966T1 (de) Wasserfreie mirtazapin-kristalle und ein verfahren zu ihrer herstellung
HUP0101230A2 (hu) Eljárás 2-[(2-piridil)-metilszulfinil]-1H-benzimidazol-származékok előállítására
Fini et al. Thermal analysis of some diclofenac salts with alkyl and alkylhydroxy amines
BRPI0815950B1 (pt) método para acelerar o amadurecimento da cana-de-açúcar usando um agente para aumentar o teor de açúcar da cana-de- açúcar
DK1295870T3 (da) Suplatasttosilatkrystaller
Booth et al. The Chemistry of Beryllium. V. Organic Compounds of Beryllium.
WO2008051541A3 (en) Process for preparing anhydrous aripirazole type i
WO2020169971A1 (en) Solidification or crystallisation method
NO20083000L (no) Tetomilast polymorfer
TH79614A (th) กรรมวิธีสำหรับการผลิตอนุพันธ์ฟิวส์ไพเพอราซิน-2-โอน
WO2006087404A1 (es) Cristalización tras dejar enfriaratorv ast atina calcica amorfa estabilizada y procedimiento para su obtención